All Stories

  1. Management of Dry Eye Disease Pre- and Post-Cataract Surgery: A Personalized Approach
  2. Mucus fishing syndrome: clinical spectrum and update on its multifactorial pathogenic mechanisms
  3. Letter to the Editor: Regarding the Efficacy of the Rho-Kinase Inhibitor for Corneal Endothelial Protection in Fuchs Endothelial Corneal Dystrophy After Phacoemulsification
  4. Complications derived from the use of the Scleral Lens/PROSE device.
  5. The etiologic and pathogenic spectrum of exposure keratopathy: Diagnostic and therapeutic implications
  6. Childhood-onset ocular mucous membrane pemphigoid presenting with peripheral ulcerative keratitis: a case report and review of the literature
  7. Latin American Consensus on Ocular Lubricants and Dry Eye Disease (LUBOS): A Report on Severity Classification, Diagnosis, and Therapy
  8. Pediatric blepharokeratoconjunctivitis: A challenging ocular surface disease
  9. Prevalence and morphometric characteristics of primary cornea guttata in a Hispanic population
  10. Recurrence of herpetic keratouveitis following cataract surgery
  11. Vogt-Koyanagi-Harada Disease Presenting as Papillitis vs. Classic Serous Retinal Detachment: A Comparative Analysis of Outcomes
  12. Validation of the Zarit Burden Interview in Informal Caregivers of Patients with Severe Visual Impairment and Blindness
  13. Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice
  14. Ocular Mucous Membrane Pemphigoid
  15. Consenso Latinoamericano de Lubricantes Oculares y Ojo Seco (LUBOS)
  16. Clinical Course and Outcomes of Autoimmune Versus Non-Autoimmune Surgically Induced Scleral Necrosis: A Multicentric Comparative Study
  17. Outcomes of accelerated corneal cross-linking for pediatric and adult keratoconus: a comparative study
  18. The visual impact of higher-order aberrations in patients with pediatric blepharokeratoconjunctivitis
  19. Actinic conjunctivitis and its relationship with prurigo in an indigenous population from the Highlands of Chiapas, Mexico
  20. Definition and Diagnostic Criteria for Pediatric Blepharokeratoconjunctivitis
  21. Reply to Letter to the Editor: Correlation and Level of Agreement between the Ocular Surface Disease Index and the Symptom Assessment in Dry Eye Questionnaires: A Survey-Based Study
  22. Wessely corneal ring phenomenon: An unsolved pathophysiological dilemma
  23. Correlation and Level of Agreement between the Ocular Surface Disease Index and the Symptom Assessment in Dry Eye Questionnaires: A Survey-Based Study
  24. CASE REPORTS: Challenges in the diagnosis and management of simultaneous bilateral toxic anterior segment syndrome after phacorefactive surgery
  25. Regarding Kaya P et al. “Predictive Factors for the Prognosis of Vogt-Koyanagi-Harada Disease”
  26. Practice patterns in the management of bacterial keratitis: a five-continent survey
  27. Letter Regarding: Clinical Characteristics and Therapeutic Outcomes of Pediatric Blepharokeratoconjunctivitis
  28. Authors’ response: Brusini and Papa's comments regarding our review article entitled: “Pigment dispersion syndrome and its implications for glaucoma”
  29. Authors’ response: Lam D, Blah TR, Francis IC. Letter to the Editor regarding the publication: “The clinical and pathogenic spectrum of surgically-induced scleral necrosis”
  30. Higher-order Aberrations and their Visual Impact in Paediatric Blepharokeratoconjunctivitis.
  31. Reproducibility, Repeatability, and Correlation of Central Corneal Thickness Measurement with the Pentacam Scheimpflug System and Ultrasound Pachymetry
  32. Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
  33. Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
  34. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease
  35. Burden and depression among informal caregivers of visually impaired patients in Mexico
  36. Age-related Changes of the Corneal Endothelium in the Hispanic Elderly Population
  37. Rheumatoid arthritis-associated peripheral ulcerative keratitis outcomes after early immunosuppressive therapy
  38. A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel
  39. The evolution of the modified osteo-odonto-keratoprosthesis, its reliability, and long-term visual rehabilitation prognosis: An analytical review
  40. Dry eye disease, a prominent manifestation of systemic autoimmune disorders
  41. Spontaneous corneal perforation in chronic trachoma
  42. Update on indications, complications, and outcomes of scleral contact lenses
  43. Current practice in the management of ocular toxoplasmosis
  44. Simultaneous clinical presentation of Vogt-Koyanagi-Harada disease and ocular tuberculosis: A diagnostic and therapeutic challenge
  45. Demographic profile and clinical course of Fuchs endothelial corneal dystrophy in Mexican patients
  46. Infectious Eye Diseases - Recent Advances in Diagnosis and Treatment
  47. Contact Lens-Associated Infectious Keratitis: Update on Diagnosis and Therapy
  48. Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications
  49. Pigment dispersion syndrome and its implications for glaucoma
  50. The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review
  51. Demographic Profile and Clinical Course of Fuchs Endothelial Corneal Dystrophy in Mexican Patients.
  52. The impact of central foveal thickness and integrity of the outer retinal layers in the visual outcome of uveitic macular edema
  53. Digital Image Processing and Development of Machine Learning Models for the Discrimination of Corneal Pathology: An Experimental Model
  54. Anterior-segment optical coherence tomography for the detection and therapeutic monitoring of corneal disorders
  55. Digital Image Processing and Development of Machine Learning Models for the Discrimination of Corneal Pathology: An Experimental Model
  56. Ramsay Hunt syndrome in a young COVID-19 patient
  57. The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review
  58. In-Vivo AS-OCT Microstructural Analysis of Herpetic Keratitis
  59. Evaluating glaucoma during the times of Covid-19: simple measures may save lives!
  60. Analysis of ocular surface damage and visual impact in patients with primary and secondary Sjögren syndrome
  61. Age-related changes of the corneal endothelium in a Hispanic elderly population.
  62. Multidisciplinary management of neurotrophic and exposure keratopathy.
  63. Introductory Chapter: Current and Future Trends in the Diagnosis and Management of Uveitis
  64. Cogan-Reese Syndrome Multimodal Imaging Analysis: OCT, UBM, and SM.
  65. ​Risk factors for ocular surface damage in dry eye
  66. Intraocular pressure variation during episodes of pigment dispersion and its relationship with the development of pigmentary glaucoma
  67. Somatolactogens and diabetic retinopathy
  68. Cataract Surgery in Patients with Uveitis: Preoperative and Surgical Considerations
  69. Efficacy and safety of pop-titrated versus fixed-energy trans-scleral diode laser cyclophotocoagulation for refractory glaucoma
  70. IL-1α and MMP-9 Tear Levels of Patients with Active Ocular Rosacea before and after Treatment with Systemic Azithromycin or Doxycycline
  71. IL-1α- und MMP-9-Konzentration in der Tränenflüssigkeit von Patienten mit aktiver okulärer Rosazea vor und nach Behandlung mit systemischem Azithromycin oder Doxycyclin
  72. Emergence of solitary juvenile xanthogranuloma on the corneoscleral limbus
  73. Eficacia del diclofenaco tópico vs. nepafenaco tópico en la reducción del dolor durante la fotocoagulación panretiniana
  74. Variación de la presión intraocular durante episodios de dispersión pigmentaria y su relación con el desarrollo de glaucoma pigmentario
  75. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis
  76. Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery
  77. In Response to: “Baddar D, Goldstein DA. HLA-A29-positive Birdshot Chorioretinopathy in a Hispanic Patient”
  78. Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome
  79. Síndrome erosivo corneal recurrente enmascarado como queratitis epitelial herpética
  80. Trans-scleral diode laser cyclophotocoagulation for refractory glaucoma after high-risk penetrating keratoplasty
  81. The Importance of an Ophthalmologic Examination in Patients With Juvenile Idiopathic Arthritis
  82. Importancia de la evaluación oftalmológica en pacientes con artritis idiopática juvenil
  83. Blefaroqueratoconjuntivitis estafilocócica en la edad pediátrica
  84. Amantadine Corneal Toxicity:Case Report and Review of the Literature
  85. Importancia del escrutinio para tuberculosis previo a la administración de agentes anti-TNF-α en uveítis: a propósito de un caso clínico
  86. Blepharokeratoconjunctivitis in pediatric patients: risk of corneal involvement and visual outcome
  87. Eficacia del ganciclovir tópico como alternativa terapéutica de la queratitis epitelial herpética
  88. Chapter-73 Serpiginous Choroiditis
  89. Pigment Dispersion Syndrome Masquerading as Acute Anterior Uveitis
  90. Secondary Glaucoma in Patients with Uveitis
  91. Outcomes in anterior uveitis associated with the HLA-B27 haplotype
  92. Recurrent uveitis in a patient with adult onset cyclic neutropenia associated with increased large granular lymphocytes
  93. The Value of Combined Serum Angiotensin-Converting Enzyme and Gallium Scan in Diagnosing Ocular Sarcoidosis
  94. Visual acuity and retinoscopy of preterm and full-term infants during the first year of life
  95. Herpes Zoster Peripheral Ulcerative Keratitis in Patients with the Acquired Immunodeficiency Syndrome
  96. Referral Patterns of Uveitis in a Tertiary Eye Care Center
  97. Systemic Drug Toxicity Trends in immunosuppressive Therapy of Immune and Inflammatory Ocular Disease
  98. Disease Relapse in Patients with Ocular Manifestations of Wegener Granulomatosis
  99. Low-dose Cyclosporin A Therapy in Treating Chronic, Noninfectious Uveitis
  100. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir
  101. The Value of Combined Serum Angiotensin-converting Enzyme and Gallium Scan in Diagnosing Ocular Sarcoidosis
  102. Systemic Immunosuppressive Therapy and the Occurrence of Malignancy in Patients with Ocular Inflammatory Disease
  103. Resistance to herpes stromal keratitis conferred by an lgG2a-derived peptide
  104. Increasing the Diagnostic Yield of Conjunctival Biopsy in Patients with Suspected Ocular Cicatricia1 Pemphigoid
  105. Disease Relapse in Patients with Ocular Manifestations of Wegener Granulomatosis
  106. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid.
  107. Posterior Segment Ocular Manifestations in Patients with HLA-B27—associated Uveitis
  108. Low-dose Cyclosporine Therapy in the Treatment of Birdshot Retinochoroidopathy
  109. Atopic keratoconjunctivitis
  110. Transitory cortical blindness post-trauma.
  111. The role of Igh-1 disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis
  112. Cyclic nucleotide mediators in latency and reactivation​ of HSV-1
  113. Ocular Manifestations​ of Systemic Granulomatous Diseases
  114. Ocular Rosacea